| Denumire comercială | DCI | Forma farmaceutică | Cod ATC | Cod CIM | Firma / țara deținătoare APP |  |
 |
 |
 |
 |
|
|---|---|---|---|---|---|---|---|---|---|---|---|
| COMIRNATY ORIGINAL/OMICRON BA.4-5 concentrat pentru dispersie injectabila | TOZINAMERAN, vacc.tipARNmCOVID-19(cu nucleozide modificate) | CONC. PT. DISPERSIE INJECTABILA | J07BX03 | W69311001 | BIONTECH MANUFACTURING GMBH - GERMANIA | X | |||||
| COMIRNATY ORIGINAL/OMICRON BA.4-5 concentrat pentru dispersie injectabila | TOZINAMERAN, vacc.tipARNmCOVID-19(cu nucleozide modificate) | CONC. PT. DISPERSIE INJECTABILA | J07BX03 | W69311002 | BIONTECH MANUFACTURING GMBH - GERMANIA | X | |||||
| COMIRNATY ORIGINAL/OMICRON BA.1 dispersie injectabila | TOZINAMERAN/RILTOZINAMERAN vacc.tipARNmCOVID-19(cu nucleozide modificate) | DISPERSIE INJECTABILA | J07BX03 | W69194001 | BIONTECH MANUFACTURING GMBH - GERMANIA | X | |||||
| COMIRNATY ORIGINAL/OMICRON BA.1 dispersie injectabila | TOZINAMERAN/RILTOZINAMERAN vacc.tipARNmCOVID-19(cu nucleozide modificate) | DISPERSIE INJECTABILA | J07BX03 | W69194002 | BIONTECH MANUFACTURING GMBH - GERMANIA | X | |||||
| COMIRNATY concentrat pentru dispersie injectabila | TOZINAMERAN, vacc.tipARNmCOVID-19(cu nucleozide modificate) | CONC. PT. DISPERSIE INJECTABILA | J07BX03 | W67224002 | BIONTECH MANUFACTURING GMBH - GERMANIA | X | |||||
| COMIRNATY concentrat pentru dispersie injectabila | TOZINAMERAN, vacc.tipARNmCOVID-19(cu nucleozide modificate) | CONC. PT. DISPERSIE INJECTABILA | J07BX03 | W69238001 | BIONTECH MANUFACTURING GMBH - GERMANIA | X | |||||
| COMIRNATY dispersie injectabila | TOZINAMERAN, vacc.tipARNmCOVID-19(cu nucleozide modificate) | DISPERSIE INJECTABILA | J07BX03 | W68306001 | BIONTECH MANUFACTURING GMBH - GERMANIA | X | |||||
| COMIRNATY dispersie injectabila | TOZINAMERAN, vacc.tipARNmCOVID-19(cu nucleozide modificate) | DISPERSIE INJECTABILA | J07BX03 | W68306002 | BIONTECH MANUFACTURING GMBH - GERMANIA | X | |||||
| COMIRNATY concentrat pentru dispersie injectabila | TOZINAMERAN, vacc.tipARNmCOVID-19(cu nucleozide modificate) | CONC. PT. DISPERSIE INJECTABILA | J07BX03 | W68305001 | BIONTECH MANUFACTURING GMBH - GERMANIA | X | |||||
| COMIRNATY concentrat pentru dispersie injectabila | TOZINAMERAN, vacc.tipARNmCOVID-19(cu nucleozide modificate) | CONC. PT. DISPERSIE INJECTABILA | J07BX03 | W68305002 | BIONTECH MANUFACTURING GMBH - GERMANIA | X | |||||
| COMBOGESIC 500 mg/150 mg | COMBINATII (PARACETAMOLUM+IBUPROFENUM) | COMPR. FILM. | N02BE51 | W68270001 | MEDOCHEMIE LTD. - CIPRU | ||||||
| COMBOGESIC 500 mg/150 mg | COMBINATII (PARACETAMOLUM+IBUPROFENUM) | COMPR. FILM. | N02BE51 | W68270002 | MEDOCHEMIE LTD. - CIPRU | ||||||
| COMBOGESIC 500 mg/150 mg | COMBINATII (PARACETAMOLUM+IBUPROFENUM) | COMPR. FILM. | N02BE51 | W68270003 | MEDOCHEMIE LTD. - CIPRU | ||||||
| COMBOGESIC 500 mg/150 mg | COMBINATII (PARACETAMOLUM+IBUPROFENUM) | COMPR. FILM. | N02BE51 | W68270004 | MEDOCHEMIE LTD. - CIPRU | ||||||
| COMBOGESIC 32 mg/ml+9,6 mg/ml | COMBINATII (PARACETAMOLUM+IBUPROFENUM) | SUSP. ORALA | N02BE51 | W69595001 | MEDOCHEMIE LTD. - CIPRU | ||||||
| COMBOGESIC 32 mg/ml+9,6 mg/ml | COMBINATII (PARACETAMOLUM+IBUPROFENUM) | SUSP. ORALA | N02BE51 | W69595002 | MEDOCHEMIE LTD. - CIPRU | ||||||
| COMBIVIR 150 mg/300 mg | COMBINATII (LAMIVUDINUM+ZIDOVUDINUM) | COMPR. FILM. | J05AR01 | W65649001 | VIIV HEALTHCARE BV - OLANDA | X | |||||
| COMBIVIR 150 mg/300 mg | COMBINATII (LAMIVUDINUM+ZIDOVUDINUM) | COMPR. FILM. | J05AR01 | W65649002 | VIIV HEALTHCARE BV - OLANDA | X | |||||
| COMBIGAN 2 mg/ml + 5 mg/ml | COMBINATII (BRIMONIDINUM+TIMOLOLUM) | PIC. OFT., SOL. | S01ED51 | W69265001 | ABBVIE LIMITED - IRLANDA | ||||||
| COMBIGAN 2 mg/ml + 5 mg/ml | COMBINATII (BRIMONIDINUM+TIMOLOLUM) | PIC. OFT., SOL. | S01ED51 | W69265002 | ABBVIE LIMITED - IRLANDA |
ANMDMR - Nomenclatorul medicamentelor pentru uz uman